NCT04739865View on ClinicalTrials.gov

The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression

PHASE2CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

August 10, 2020

Primary Completion Date

October 14, 2021

Study Completion Date

October 14, 2021

Conditions

Treatment Resistant Depression

Interventions

DRUG

Psilocybin

Open label

Trial Locations (2)

92037

Kadima Neuropsychiatry Institute, La Jolla

Unknown

Sheaf House, Tallaght Hospital, Dublin

Sponsors

Lead Sponsor

COMPASS Pathways

All Listed Sponsors

lead

COMPASS Pathways

INDUSTRY